TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from PYC Therapeutics Limited ( (AU:PYC) ) is now available.
PYC Therapeutics Limited has announced that its Annual General Meeting will be held on November 18, 2025, at the Harry Perkins Institute of Medical Research in Western Australia. The meeting will be accessible both in-person and via Zoom, allowing shareholders to participate remotely, which reflects the company’s commitment to engaging with its stakeholders and maintaining transparency in its operations.
The most recent analyst rating on (AU:PYC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on PYC Therapeutics Limited stock, see the AU:PYC Stock Forecast page.
More about PYC Therapeutics Limited
PYC Therapeutics Limited operates in the biotechnology industry, focusing on developing precision medicines for genetic diseases. The company specializes in RNA therapeutics, aiming to address unmet medical needs in the field of genetic disorders.
Average Trading Volume: 754,295
Technical Sentiment Signal: Hold
Current Market Cap: A$679.5M
For a thorough assessment of PYC stock, go to TipRanks’ Stock Analysis page.